1. Home
  2. ELVA vs BNTC Comparison

ELVA vs BNTC Comparison

Compare ELVA & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Electrovaya Inc.

ELVA

Electrovaya Inc.

HOLD

Current Price

$5.09

Market Cap

328.2M

Sector

N/A

ML Signal

HOLD

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$8.11

Market Cap

313.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELVA
BNTC
Founded
1996
1995
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
328.2M
313.9M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
ELVA
BNTC
Price
$5.09
$8.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
7
Target Price
$14.60
★ $24.33
AVG Volume (30 Days)
★ 348.7K
187.5K
Earning Date
08-10-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 6.67
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$11.31
N/A
Revenue Next Year
$47.43
N/A
P/E Ratio
$78.51
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.10
$8.25
52 Week High
$12.78
$16.76

Technical Indicators

Market Signals
Indicator
ELVA
BNTC
Relative Strength Index (RSI) 30.77 28.71
Support Level N/A N/A
Resistance Level $6.85 $14.09
Average True Range (ATR) 0.30 0.62
MACD -0.09 -0.02
Stochastic Oscillator 8.09 4.83

Price Performance

Historical Comparison
ELVA
BNTC

About ELVA Electrovaya Inc.

Electrovaya Inc is a technology-focused lithium-ion battery company engaged in designing, developing and manufacturing battery cells, modules and systems based on its proprietary Infinity Battery Technology, which provides high safety performance, long cycle life and durability. The Company supplies low-voltage and high-voltage battery systems for industrial and transportation markets, including material-handling equipment, robotic vehicles, electric buses and trucks, and energy-storage installations, and its products are suitable for mission-critical applications. it maintains an expanding intellectual-property portfolio, develops next-generation solid-state and hybrid solid-state battery technologies, and sells its products through OEM relationships, dealer networks and direct sales.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.

Share on Social Networks: